Amersham, UK, Minnesota, USA, and Melbourne, Australia — 30 July 2020 — GE Healthcare and Osprey Medical Inc. (ASX:OSP) (Osprey) today announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, Middle East, Africa, Central Asia and Turkey. Osprey’s DyeVertTM contrast minimization devices, […]
Author: Ken Dropiewski
Endologix Announces First Commercial Implant of ALTO Abdominal Stent Graft System & Official Start of U.S. Commercial Release
IRVINE, Calif.–(BUSINESS WIRE)–Transforming the treatment of aortic disorders, Endologix® Inc. (OTC: ELGXQ) (“Endologix” or the “Company”), today announced the first commercial implant and the U.S. commercial release of its recently FDA-approved ALTO® endograft for the treatment of abdominal aortic aneurysms (AAA). “ALTO represents a differentiation from traditional endovascular aneurysm repair (EVAR) and, […]
Blue Sail Shanghai Innovation Center (BSIC) Launched at ATLATL
SHANGHAI–(BUSINESS WIRE)–BLUE SAIL MEDICAL CO., LTD. (Blue Sail) opened its Blue Sail Shanghai Innovation Center (BSIC) in July 2020 at ATLATL Innovation Center, which built the customized GMP facility after a 10-month effort. Blue Sail is the world’s largest vinyl glove enterprise (Shenzhen SE code: 002382). Blue Sail entered the […]
Large Multi-Center Study in Japan Finds High Survival Rates with Use of Impella Heart Pump
Study conducted at 109 hospitals with oversight by 10 Japanese professional societies, including Japanese Circulation Society TOKYO–(BUSINESS WIRE)–A three-year, investigator-led, prospective study of Japanese patients who received an Impella heart pump finds use of Impella is associated with a 77% survival rate at 30 days in AMI cardiogenic shock patients. The historic […]
Empagliflozin meets primary endpoint in reducing risk of cardiovascular death or hospitalization for heart failure in Phase III trial in adults with and without diabetes
– Empagliflozin significantly reduced the risk of cardiovascular death or hospitalization for heart failure versus placebo in the EMPEROR-Reduced heart failure trial. The study evaluated adults with heart failure with reduced ejection fraction – Treatment of heart failure is an important unmet need with over half of those diagnosed dying within five […]
Ontrak achieves HITRUST CSF® Certification to further mitigate risk in third-party privacy, security, and compliance
HITRUST CSF Certification validates Ontrak is committed to meeting key regulations and protecting sensitive information SANTA MONICA, Calif.–(BUSINESS WIRE)–Ontrak, Inc. (NASDAQ: OTRK) (“Ontrak” or the “Company”), a leading AI and technology-enabled healthcare company, today announced that the company’s data pipeline system, eOntrak Case Management System and supporting technology infrastructure have […]
BioTelemetry, Inc. Announces Sales Agent Agreement with Boston Scientific Corporation
Company expands portfolio of solutions with groundbreaking insertable cardiac monitor system MALVERN, Pa., July 30, 2020 (GLOBE NEWSWIRE) — BioTelemetry, Inc. (NASDAQ:BEAT), the leading remote medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, today announced a sales agent […]
CHF Solutions Further Expands Commercial Presence in the Middle East with Distribution Arrangement for Israel and Palestine
EDEN PRAIRIE, Minn., July 30, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announced the signing of a distribution agreement with SysteMedic Ltd., covering Israel and Palestine, representing the second distribution partnership in the Middle East region. Ultrafiltration therapy is now available in 16 countries outside the U.S. Ninety […]
Remote hypertension tracking program delivers peace of mind to patients
247 Health Solution and Adventist Health to launch innovative remote patient hypertension tracking program LOS ANGELES, July 30, 2020 /PRNewswire/ — 247 Health Solution and Adventist Health have partnered together to offer patients an innovative remote hypertension tracking program beginning in August 2020. The Adventist Health pilot will use 247 Health Solution’s Remote […]
JanOne bolsters its scientific advisory board with two leaders in the medical field for vascular regeneration and interventional pain
Houston Methodist Research Institute Professor and Chair of the Department of Cardiovascular Sciences Dr. John Cooke and LSU Health Shreveport Vice Chancellor Dr. Alan Kaye Join the JanOne Team LAS VEGAS, July 30, 2020 /PRNewswire/ — JanOne Inc. (NASDAQ:JAN), a company focused on finding treatments for conditions that cause severe pain and bringing […]



